Home/ Stocks/ IMTX

Immatics N.V. Ordinary Shares

IMTX XNAS

$10.06 +0.00 (+0.00%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$1.35B

About Immatics N.V. Ordinary Shares

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Employees: 423 Website →

Ticker Daily Articles on IMTX

How to Find Penny Stocks Before They Spike: 7 Research Methods That Work

Marcus Rivera · 5h ago · News

Get IMTX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Immatics N.V. Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.